The Impact Of The Corporate Social Strategy (Csr) On The Supply Chain Strategy In The Pharmaceutical Industry: The Case Of Mitsubishi Tenabe Pharma Corporation

Read Complete Research Material



[The Impact of the Corporate Social Strategy (CSR) on the Supply Chain Strategy in the Pharmaceutical Industry: The Case of Mitsubishi Tenabe Pharma Corporation]

By

Acknowledgement

I would take this opportunity to thank my research supervisor, family and friends for their support and guidance without which this research would not have been possible.

DECLARATION

I, [type your full first names and surname here], declare that the contents of this dissertation/thesis represent my own unaided work, and that the dissertation/thesis has not previously been submitted for academic examination towards any qualification. Furthermore, it represents my own opinions and not necessarily those of the University.

Signed __________________ Date _________________

Abstract

The main ambition of a business is to earn a profit and in a lucrative way. In order to fulfil this ambition organizations and businesses prefer to adopt processes and methods that would aid them in fulfilling this objective. Some businesses adopt the specialized process of production some rely on marketing function and then there are those that specializes the process of supply chain management. Supply chain management is a function that is often ignored by the organization. If it is devised and implement carefully it can even lend a hand for an organization to gain competitive advantage. This paper also talks about the phenomenon of CSR in supply chain management. In this paper, CSR related to supply chain management of Mitsubishi Tenabe Pharma Corporation is discussed from variegated aspects.

Table of Contents

ACKNOWLEDGEMENTII

DECLARATIONIII

ABSTRACTIV

CHAPTER 1: INTRODUCTION1

Background of the study1

Problem Statement2

Purpose of the study3

Significance of the study3

Rationale of the study4

CHAPTER 2: LITERATURE REVIEW7

Supply Chain Management7

Supply Chain Management in Mitsubishi Tenabe Pharma Corporation Pharmaceutical Industry9

Contemporary practices in supply chain management11

A community PSC network with reverse logistics11

Four basic components of Supply Chain Management in Pharmaceutical industry13

A Cross Boundary Green PSC15

The wholesaler and logistics providers17

Community Pharmacies17

Supplier certification and cooperation18

Professional and regulatory bodies and waste management companies19

A Green PSC19

Corporate Social and Environmental Strategy for pharmaceutical industry21

CSR Reports23

Corporate Social Image24

CR and SGSM25

CHAPTER 3: METHODOLOGY29

Research Design30

Secondary Research Methods31

Qualitative and quantitative research method33

Instrument36

Target population37

Reliability and validity37

Ethical Concerns42

Literature Search43

Keywords Used44

CHAPTER 4: ANALYSIS AND DISCUSSION45

CSR on Supply Chain Management in Mitsubishi Tenabe Pharma Corporation45

Analysis of the questionnaire from employees49

Analysis of the interview responses60

CHAPTER 5: CONCLUSION64

REFERENCES69

CHAPTER 1: INTRODUCTION

Background of the study

To flourish and survive in today's competitive global marketplace, firms are increasingly focusing on their core competencies and turning towards outsource functions in which they possess no expertise to maintain effective cost structures and to improve their top and bottom lines. In today's hypercompetitive global marketplace no one firm can go it alone and become successful in search of market opportunities in near real-time and cost-effective fashion because of lack of key talents and knowledge experience bases (Adam, 2004, pp. 225-44).

Due to few blockbuster drugs in the pipeline chain and competition from generics firms, the pharmaceutical firms are increasingly scrutinizing their operations to improve shareholders' value and profit margins. In particular, the practice of pharmaceutical outsourcing has become more than ever a viable strategic business option to gain competitive advantage (Agrawal, 2005, pp. 798-805). The most commonly cited reasons for the increase in ...